Mindray Medical International Ltd. (MR-N) Stock Predictions - Stockchase
WATCH LIST
3
Mindray Medical International Ltd. (MR-N)

ON STOCKCHASE SINCE May 2008

Taken Private March 2016

biotechnology/pharmaceutical

Mindray Medical Internati...

MR-N

0 watching          
Join the Discussion

Mindray Medical International Ltd. (MR-N) SAVE Apr, 19, 2019, 8:43 am

13.28 0.3 (2.21%)

This company is not ACTIVE.

What the experts are saying about MR-N



  • All
  • Filtered
Signal Opinion Expert
PAST TOP PICK
(A Top Pick Aug 8/08. Down 18%.) Chinese company that makes imaging equipment that got FDA approval about 18 months ago. Earnings growth has tapered off. Now trading in a very flat consolidation and technically it looks like it is going to go higher.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Aug 8/08. Down 18%.) Chinese company that makes imaging equipment that got FDA approval about 18 months ago. Earnings growth has tapered off. Now trading in a very flat consolidation and technically it looks like it is going to go higher.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Paul Thornton

President, Investor Boot Camp O...

Price Price
$30.970
Owned Owned
No

TOP PICK
Manufactures imaging equipment. The selloff on Thursday was too large for the breakout so if the stock undercuts $36 you want to get out. Volatile and a bit erratic. Very good earnings growth and they got FDA approval last year so there is a lot of room for growth.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Manufactures imaging equipment. The selloff on Thursday was too large for the breakout so if the stock undercuts $36 you want to get out. Volatile and a bit erratic. Very good earnings growth and they got FDA approval last year so there is a lot of room for growth.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Paul Thornton

President, Investor Boot Camp O...

Price Price
$37.910
Owned Owned
Yes

BUY
Pretty diversified but really a play on medical devices and medical testing in China. Layer on the demographics and the need for continued health-care and support for that from the Chinese government. Stocks have been really beaten down but the businesses are still growing. Likes this one for the dynamics.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Pretty diversified but really a play on medical devices and medical testing in China. Layer on the demographics and the need for continued health-care and support for that from the Chinese government. Stocks have been really beaten down but the businesses are still growing. Likes this one for the dynamics.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Cameron Webster

Managing P, Sandstone Asset Mana...

Price Price
$39.550
Owned Owned
No

Showing 1 to 3 of 3 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days